IP Library Granted Patent US 11,612,559
Granted Patent B2
US 11,612,559 · App. 17/509,830 · Granted Mar 28, 2023

Cosmetic compositions

Inventors: Tiffany Carle (Addison, TX); Milagros Sanchez (Addison, TX); David Gan (Addison, TX)
Assignee: MARY KAY INC.
A61K8/9789A61K8/06A61K8/11A61K8/676A61K8/678A61Q19/007A61Q19/08A61K8/44A61K2800/412A61K2800/413
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,612,559
App. No.
17/509,830
Granted
Mar 28, 2023
Kind
B2
Abstract

Disclosed is a method of improving a condition or appearance of skin. The method can include applying to skin an effective amount of a topical skin composition comprising tetrahexyldecyl ascorbate, Phyllanthus emblica fruit extract, and tocopherol or tocopherol acetate.

Claims (23)

1. A method of improving a condition or appearance of skin comprising applying to the skin an effective amount of a topical skin composition comprising tetrahexyldecyl ascorbate, Phyllanthus emblica fruit extract, tocopherol or tocopherol acetate, one or more additional vitamin C compound, one or more moisturizing agent, one or more emulsifier, and water, wherein the moisturizing agent comprises sunflower seed oil, behenyl alcohol, sodium hyaluronate, and glycerin, and wherein the one or more emulsifier comprises arachidyl alcohol and arachidyl glucoside.

2. The method of claim 1 , wherein the one or more additional vitamin C compound comprises an ascorbic acid derivative.

3. The method of claim 1 , wherein the topical skin composition comprises tocopherol.

4. The method of claim 1 , wherein the topical skin composition further comprises a preservative.

5. The method of claim 1 , wherein the topical skin composition is a serum.

6. The method of claim 1 , wherein, by applying the topical skin composition, the skin is treated to inhibit melanogenesis and/or tyrosinase.

7. The method of claim 1 , wherein by applying the topical skin composition, the skin is treated to inhibit hyperpigmentation.

8. The method of claim 1 , wherein by applying the topical skin composition, the skin is hydrated.

9. The method of claim 1 , wherein by applying the topical skin composition, collagen production in the skin is increased.

10. The method of claim 9 , wherein by applying the topical skin composition, skin radiance is increased.

11. The method of claim 1 , wherein, by applying the topical skin composition, the skin is treated to:

improve a skin condition comprising skin radiance, skin tone clarity, skin brightness, skin tone evenness, or combinations thereof;

to reduce a skin condition comprising photo damage, loss of facial firmness, fine lines, deep lines, wrinkles, skin dullness, skin sagging, appearance of age spots on skin, or combinations thereof; and

to increase moisture level of the skin.

12. The method of claim 11 , wherein, by applying the topical skin composition, the skin moisture level is increased within about 15 minutes of applying the topical skin composition.

13. The method of claim 1 , wherein, by applying the topical skin composition, the skin is treated to inhibit matrix metalloproteinase enzyme activity, to stimulate production of matrix proteins that comprise collagen, and/or lysyl oxidase, and/or to inhibit production of cyclooxygenase-1.

14. The method of claim 13 , wherein the matrix metalloproteinase enzyme includes MMP3.

15. The method of claim 1 , wherein the Phyllanthus emblica fruit extract is an aqueous extract from Phyllanthus emblica fruit.

16. The method of claim 1 , wherein the topical skin composition is applied to a fine line or wrinkle.

17. The method of claim 1 , wherein the topical skin composition is applied to an age spot.

18. The method of claim 1 , wherein the topical skin composition is applied to facial skin including the periorbital region and/or the crow's feet region of the skin, and/or neck skin.

19. The method of claim 1 , wherein, after topical application, the topical skin composition remains on the skin for at least 30 minutes.

20. The method of claim 1 , wherein the topical skin composition is applied one or more times daily for at least 4 weeks.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2024
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 068354/0474 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2021
From: CARLE, TIFFANY; SANCHEZ, MILAGROS; GAN, DAVID
To: MARY KAY INC.
Reel/Frame 057903/0042 →
Continuity (3)
Continuation 16706290 · Dec 6, 2019
Provisional Application 62780036 · Dec 14, 2018
Related Publication 20220218594A1 · Jul 14, 2022